FIELD: medicine; toxicology.
SUBSTANCE: patients take peritoneal examination by means of introduction of specially prepared solution. For that purpose albumin dosed 60-100 g/l and phracsiparin dosed 0.3-0.8 g/l are mixed during 3-5 minutes and then this mixture is added to dialyzing solution during 10-15 minutes through infusion system. After that solution is introduced to abdominal cavity for 5-7 hours.
EFFECT: provides prolongation of peritoneal examination procedure.
2 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
SOLUTION FOR PERITONEAL DIALYSIS | 2014 |
|
RU2567043C1 |
BODY DETOXIFICATION PROCEDURE | 2013 |
|
RU2530759C1 |
METHOD FOR ASSESSING EFFECTIVENESS OF DIALYSIS THERAPY ACCOMPANYING DETOXIFICATION | 2014 |
|
RU2569755C1 |
METHOD OF ESTIMATING ANTIBACTERIAL THERAPY EFFICIENCY IN CASE OF DIALYSIS PERITONITIS | 2014 |
|
RU2567732C1 |
METHOD FOR TREATING HEPATIC FAILURE | 2004 |
|
RU2269363C1 |
METHOD OF TREATING SEPSIS IN TREATING ABDOMINAL ORGANS COMPLICATED BY HEPATIC FAILURE | 2014 |
|
RU2572019C1 |
METHOD FOR INCREASING EFFECTIVENESS OF HEMODIAFILTRATION IN ACUTE HEPATIC FAILURE IN CARDIOSURGICAL PATIENTS | 2012 |
|
RU2483757C1 |
METHOD OF IMPLANTING PERITONEAL CATHETER | 2013 |
|
RU2560906C2 |
METHOD FOR RECOVERY OF PERITONEAL CATHETER DRAINAGE FUNCTION | 2020 |
|
RU2740426C1 |
METHOD FOR PREVENTING INFECTIOUS COMPLICATIONS ASSOCIATED WITH THE PERITONEAL CATHETER INSTALLATION IN THE PATIENTS WITH CHRONIC C5 RENAL DISEASE ON PERITONEAL DIALYSIS | 2018 |
|
RU2690951C1 |
Authors
Dates
2008-05-27—Published
2006-10-11—Filed